The emerging treatment of the medication represents a significant advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide094734.bloguerosa.com/40642539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment